An analysis of 58 non-listed life insurers for the first half of 2026 reveals a striking contrast in performance. The sector posted a combined net profit of 61.686 billion yuan, a staggering 108.6% year-on-year increase, with 51 companies achieving profitability, representing nearly 90%, and 13 firms turning losses into gains. This, combined with nearly 10% premium growth and a near-doubling of participating insurance premiums, has fueled a narrative of a "full-scale life insurance recovery."
However, peeling back the profit surface reveals a different picture. The top 14 companies captured over 80% of the industry's total profit, while smaller firms still struggle near breakeven. Some products have a staggering comprehensive surrender rate of 2189%, indicating hidden capital outflows. Nearly 80% of companies experienced changes in their "directors, supervisors, and senior management," signaling heightened management instability. Moreover, several insurers have seen their solvency ratios fall below regulatory minimums, highlighting capital pressure. The key question is whether this profit doubling reflects genuine value transformation or a superficial boom driven by capital markets and accounting standards.
66.16 Billion Yuan Profit Doubling: A Tiered Rally Dominated by Head Players
From an aggregate perspective, the growth of the non-listed life insurance sector in the first half of 2026 appears robust. The 58 companies collectively generated approximately 796.3 billion yuan in insurance business income, a year-on-year increase of about 10% (excluding China Life Pension Company). The original premium income from participating insurance for the entire industry's life insurers reached about 1.01 trillion yuan, a massive 94.4% surge, making it the primary driver of premium growth. The doubling of net profit serves as the core evidence for the "recovery theory."
Yet, the distribution of profits reveals the industry's true condition more accurately than the total figures. The profit structure is an extreme "pyramid": the top 14 companies, each with net profits exceeding 1 billion yuan, contributed a combined 48.557 billion yuan, accounting for 80.34% of the industry's total profit. The next 28 companies, with profits between 100 million and 1 billion yuan, contributed 12.352 billion yuan, or 20.44%. The 8 companies with profits under 100 million yuan collectively earned only 366 million yuan, while the remaining 7 loss-making companies reported a combined loss of 831 million yuan. This means less than a quarter of the companies captured over 80% of the industry's profits, while over 70% of the smaller firms fought for less than 20% of the profit pie, illustrating the extreme Matthew Effect in the life insurance industry.
Within the top tier, Taikang Life Insurance Co., Ltd. led dramatically with a net profit of 15.821 billion yuan, though it saw a slight 1.1% year-on-year decline, a notable anomaly against the backdrop of the industry's profit doubling. China Post Life Insurance Co., Ltd. and ICBC-AXA Life Insurance Co., Ltd. followed with 7.068 billion yuan and 4.317 billion yuan, respectively. Bank-affiliated insurers were the biggest winners in the first half. Six bank-affiliated companies—including China Post Life, ICBC-AXA Life, ABC Life Insurance Co., Ltd., CCB Life Insurance Co., Ltd., Cigna & CMB Life Insurance Co., Ltd., and BOCOM Life Insurance Co., Ltd.—reported a combined net profit of nearly 21 billion yuan, representing about 43% of the profits of the top 14. Leveraging their parent banks' distribution channels, these insurers gained a significant advantage in the participating insurance wave. However, whether this growth, reliant on "blood transfusion" sales from parent banks, can translate into sustained endogenous value creation remains to be seen.
A more concerning issue is the mismatch between premium scale and profitability. Lian Life Insurance Co., Ltd. generated 19.585 billion yuan in premiums in the first half, ranking in the industry's mid-tier, but its net profit was only 390 million yuan, resulting in a profit margin below 2%—a classic case of "large but not strong." In contrast, PKU-Prudential Life Insurance Co., Ltd. had a premium scale of only 2.691 billion yuan but achieved a net profit of 688 million yuan, a profit margin exceeding 25%, following a "small but beautiful" model. The failure of scale expansion to translate into profit reflects that some companies still rely on low-value, volume-driven products to boost premiums, indicating that value transformation is not yet fully implemented.
Investment Dependence and Surrender Risks: Structural Cracks Beneath the Boom
Behind the profit doubling are two key drivers: the strong performance of the capital market in the first half and the implementation of new accounting standards, which amplified profit elasticity. These factors also constitute the fragility of this profit growth. In the first half of 2026, the A-share market experienced a structural bull run, with the STAR 50 Index surging over 64% and the ChiNext Index rising 35.58%. Insurers that had pre-positioned in sectors like semiconductors and AI saw significant increases in investment returns, becoming the primary driver of profit growth. Data shows that the median comprehensive investment return for the 58 companies was 2.46%, with a median investment return of 1.94%.
Simultaneously, 2026 is the first year for non-listed insurers to fully implement the new accounting standards IFRS 17 and IFRS 9 (some listed insurers adopted them earlier in 2023). On the liability side, the discount rate has shifted from the 750-day moving average to the spot rate on the balance sheet date. Changes in the fair value of equity assets are now directly recorded in current period profits. This effectively installs an "amplifier" for insurers' profits—profits accelerate when the market rises, but losses also amplify when the market falls. Long Ge, a scholar from the School of Insurance & Economics at the University of International Business and Economics, noted that under the new standards, insurers' profits become significantly more sensitive to interest rates and capital market movements, making performance volatility a normal occurrence.
The risks of this "weather-dependent" profit model are already evident. Xiaokang Life Insurance Co., Ltd. became the most typical case of "flip-flopping" in the first half, swinging from profitability in 2025 to a net loss of 508 million yuan, a profit decline of 418.82%, ranking first in losses. Its comprehensive investment return plummeted from 11.64% last year to -5.24%, directly linking investment volatility to the company's financial results. A compelling question is: if the capital market retraces in the second half, how many more "Xiaokang Lifes" will emerge?
In fact, the divergence in investment capabilities within the industry was predetermined. The median investment return for the 58 companies was only 1.94%, far below the level of top players. This indicates that most companies' investment income growth relies on market beta rather than their own active management skills. Once market trends reverse, industry profits could quickly "ebb."
A more insidious risk than profit volatility is hidden in the surrender data. According to statistics, the top three surrendered products across 57 companies resulted in a total surrender scale of 22.19 billion yuan, with capital outflows from these three products alone exceeding 20 billion yuan. Taikang Life Insurance Co., Ltd., China Post Life Insurance Co., Ltd., and CITIC-Prudential Life Insurance Co., Ltd. ranked as the top three in terms of company surrender amounts, with 4.134 billion yuan, 3.153 billion yuan, and 3.067 billion yuan, respectively. Among individual products, CITIC-Prudential's "Zhi Shang Ren Sheng" Annuity Insurance C saw a surrender amount of 2.437 billion yuan, topping the list.
Even more alarming are the abnormal surrender rates of certain products. Among the 168 products surveyed, the median comprehensive surrender rate was 7.20%, but 14 products had surrender rates exceeding 50%, and 5 exceeded 100%. Two cancer insurance products for middle-aged and elderly individuals from Ergo China Life Insurance Co., Ltd. had surrender rates of 216.70% and 174.91%, respectively. While extremely high surrender rates often correspond to small business bases, the concentration of such products in the endowment and senior cancer insurance segments raises concerns about potential sales misconduct or product design flaws, warranting vigilance from regulators and consumers.
Pressure on the solvency front is also becoming apparent. Across the industry, two companies failed to meet solvency requirements, 20 companies saw a decline in net assets, and the overall industry solvency decreased quarter-over-quarter. Nissay-Greatwall Life Insurance Co., Ltd. has already crossed the regulatory red line. As of the end of the first quarter, its core solvency adequacy ratio was only 45.4%, and its comprehensive solvency adequacy ratio was 55.5%, both below regulatory requirements. Its net assets were negative, at approximately -413 million yuan. The company predicts that these two indicators may further deteriorate to 21.6% and 34.5% by the end of the second quarter. It is currently undergoing a capital increase and share expansion. If capital replenishment falls short of expectations, it could face regulatory measures restricting its business scope.
Management Shake-up and Capital Pressure: The Industry's Growing Pains in the Deep End of Transition
Behind the earnings volatility lies deep-seated governance turmoil and capital market changes. Second-quarter data shows that among the 58 non-listed life insurers, 46 experienced changes in key "director, supervisor, and senior management" positions, accounting for nearly 80%. This resulted in 142 records of changes involving 128 individuals, including 73 departures and 66 new appointments. This dense turnover in management has become another notable feature of the industry in the first half. Guolian Life Insurance Co., Ltd. was the most frequent company in terms of personnel changes, with 14 individuals and 16 change records. Ergo China Life Insurance Co., Ltd., Aegon THTF Life Insurance Co., Ltd., and Happy Life Insurance Co., Ltd. all had more than 7 personnel changes. Happy Life, in particular, has experienced continuous management reshuffling in recent years, with strategic direction shifts intertwined with personnel turmoil.
A more noteworthy change in governance structure is that three companies—CITIC-Prudential Life Insurance Co., Ltd., Minsheng Life Insurance Co., Ltd., and Haibao Life Insurance Co., Ltd.—have abolished their board of supervisors, with related oversight responsibilities transferred to the audit committee of the board of directors. Whether this adjustment represents an optimization for efficiency or a weakening of oversight functions remains a subject of debate.
Behind the personnel turmoil is the strategic confusion of the industry during its transition period. For most small and medium-sized insurers, under the backdrop of tightening regulations on "reporting and implementation consistency" and accelerating channel reforms, the old model of relying on bancassurance channels for scale and investment returns for profits is no longer sustainable. However, new pathways for value growth have not yet been established. Replacing management is often the first choice for shareholders trying to break through, but frequent management changes can interrupt strategic continuity, trapping companies in a cycle of "more changes, more chaos."
On the capital front, the industry shows a pattern of "heavy debt issuance, slow capital increase." In the first half, 11 non-listed life insurers raised capital through bond issuance and capital increases, totaling 18.4 billion yuan. Seven companies issued capital bonds totaling 13.5 billion yuan, with CITIC-Prudential Life Insurance Co., Ltd.'s 4 billion yuan perpetual capital bond being the largest. Four companies completed capital increases totaling 4.901 billion yuan, with Guobao Life Insurance Co., Ltd.'s 3.075 billion yuan increase being the highest. 2026 is the first full year after the end of the transition period for the second phase of the "C-ROSS" (China Risk-Oriented Solvency System). Insurers generally build capital buffers through debt issuance, but shareholders' willingness to increase capital is significantly cooling, making capital replenishment channels for small and medium-sized companies increasingly narrow.
The investment side shows a clear pattern of divergence. In the first half, five companies disclosed major investments totaling 1.791 billion yuan. Taikang Life Insurance Co., Ltd. alone accounted for 42 transactions totaling 1.396 billion yuan, representing 77.97% of the industry's total investment. Nearly all of these investments were directed towards senior living communities and medical management sectors. During the downturn of the real estate industry, Taikang's counter-cyclical increase in heavy-asset retirement real estate represents both a long-term bet on the "insurance + elderly care" model and a test of the challenges of long investment return cycles and high capital lock-up pressure.
Looking at this half-year report, the industry's true state is clear: the profit has doubled, but its quality is insufficient. Growth is primarily driven by capital market conditions and the dividend from new accounting standards, not a substantive improvement in operational capabilities. The Matthew Effect continues to intensify, with top companies growing stronger and the survival space for small and medium-sized insurers shrinking. Surrender risks are lurking, with abnormally high surrender rates for certain products exposing flaws in product design and sales. The dense turnover in management reflects the strategic confusion and governance pains of the industry's transition. Solvency pressure is diverging, making capital replenishment a life-or-death issue for some companies.
In 2026, the life insurance industry is in the deep end of its transition from "scale expansion" to "value-oriented operations." The new accounting standards amplify performance volatility, the "reporting and implementation consistency" policy compresses room for extensive growth, and small and medium-sized companies face a triple squeeze on channels, branding, and capital. Beyond the superficial celebration of 60 billion yuan in profits, the real test for the industry is just beginning. Only those companies that can navigate cyclical fluctuations and truly build endogenous value creation capabilities will be able to stand firm in the next round of industry consolidation.
Comments